{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T10:06:36Z","timestamp":1777975596741,"version":"3.51.4"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"48","license":[{"start":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T00:00:00Z","timestamp":1539648000000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/www.nationalarchives.gov.uk\/doc\/open-government-licence\/version\/3\/"}],"funder":[{"name":"Abbott Vascular Int"},{"name":"Amgen Cardiovascular"},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer AG","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008497","name":"Boston Scientific","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Bristol Myers Squibb and Pfizer Alliance"},{"name":"Daiichi Sankyo Europe GmbH"},{"name":"The Alliance Daiichi Sankyo Europe GmbH"},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006520","name":"Edwards","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100006520","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Gedeon Richter Plc"},{"name":"Menarini Int. Op"},{"name":"MSD-Merck & Co"},{"name":"Novartis Pharma AG"},{"name":"ResMed"},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011725","name":"SERVIER","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100011725","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,12,21]]},"DOI":"10.1093\/eurheartj\/ehy626","type":"journal-article","created":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T19:16:51Z","timestamp":1537298211000},"page":"4277-4284","source":"Crossref","is-referenced-by-count":257,"title":["Prognostic implications of atrial fibrillation in heart failure with reduced, mid-range, and preserved ejection fraction: a report from 14\u2009964 patients in the European Society of Cardiology Heart Failure Long-Term Registry"],"prefix":"10.1093","volume":"39","author":[{"given":"Barak","family":"Zafrir","sequence":"first","affiliation":[{"name":"Department of Cardiology, Lady Davis Carmel Medical Center, Haifa, Israel"}]},{"given":"Lars H","family":"Lund","sequence":"additional","affiliation":[{"name":"Heart and Vascular Theme, Karolinska University Hospital, Stockholm"},{"name":"Department of Medicine, Karolinska Institutet, Stockholm, Sweden"}]},{"given":"Cecile","family":"Laroche","sequence":"additional","affiliation":[{"name":"EURObservational Research Programme, European Society of Cardiology, Sophia-Antipolis, France"}]},{"given":"Frank","family":"Ruschitzka","sequence":"additional","affiliation":[{"name":"Heart Failure and Transplantation Clinic, University Hospital Zurich, Zurich, Switzerland"}]},{"given":"Maria G","family":"Crespo-Leiro","sequence":"additional","affiliation":[{"name":"Unidad de Insuficiencia Cardiaca y Trasplante Cardiaco, Complexo Hospitalario Universitario A Coruna (CHUAC), INIBIC, UDC, CIBERCV, La Coruna, Spain"}]},{"given":"Andrew J S","family":"Coats","sequence":"additional","affiliation":[{"name":"IRCCS, San Raffaele, Pisana, Rome, Italy"}]},{"given":"Stefan D","family":"Anker","sequence":"additional","affiliation":[{"name":"Division of Cardiology and Metabolism, Department of Cardiology (CVK), Berlin-Brandenburg Center for Regenerative Therapies (BCRT), German Centre for Cardiovascular Research (DZHK) Partner Site Berlin, Charit\u00e9 Universit\u00e4tsmedizin Berlin, Germany"},{"name":"Department of Cardiology and Pneumology, University Medicine G\u00f6ttingen (UMG), G\u00f6ttingen, Germany"}]},{"given":"Gerasimos","family":"Filippatos","sequence":"additional","affiliation":[{"name":"Heart Failure Unit, Department of Cardiology, Athens University Hospital Attikon, Athens, Greece"}]},{"given":"Petar M","family":"Seferovic","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Clinical Centre of Serbia, Belgrade, Serbia"}]},{"given":"Aldo P","family":"Maggioni","sequence":"additional","affiliation":[{"name":"EURObservational Research Programme, European Society of Cardiology, Sophia-Antipolis, France"},{"name":"ANMCO Research Center, Florence, Italy"}]},{"given":"Manuel","family":"De Mora Martin","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Hospital Regional Universitario Carlos Haya, Malaga, Spain"}]},{"given":"Lech","family":"Polonski","sequence":"additional","affiliation":[{"name":"Slaskie Centrum Chorob Serca, Zabrze, Poland"}]},{"given":"Jos\u00e9","family":"Silva-Cardoso","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Faculty of Medicine of Porto University, Hospital de Sao Joao, Porto, Portugal"}]},{"given":"Offer","family":"Amir","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Poriya Medical Center, Tiberius, Israel"},{"name":"The Azrieli Faculty of Medicine in the Galilee, Bar-Ilan University, Safed 1311502, Israel"}]},{"name":"ESC-HFA HF Long-Term Registry Investigators","sequence":"additional","affiliation":[]}],"member":"286","published-online":{"date-parts":[[2018,10,15]]},"reference":[{"key":"key\n\t\t\t\t2018122103591472700_ehy626-B1","first-page":"1142","article-title":"Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population","volume":"112","author":"Colilla","year":"2013","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t2018122103591472700_ehy626-B2","article-title":"Temporal trends in incidence, prevalence, and mortality of atrial fibrillation in primary care","volume":"6","author":"Lane","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"key\n\t\t\t\t2018122103591472700_ehy626-B3","first-page":"250","article-title":"Clinical course of atrial fibrillation in older adults: the importance of cardiovascular events beyond stroke","volume":"35","author":"Piccini","year":"2014","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t2018122103591472700_ehy626-B4","first-page":"2508","article-title":"Causes of death in anticoagulated patients with atrial fibrillation","volume":"68","author":"G\u00f3mez-Outes","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t2018122103591472700_ehy626-B5","first-page":"2129","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t2018122103591472700_ehy626-B6","first-page":"369","article-title":"Associations between atrial fibrillation and early outcomes of patients with heart failure and reduced or preserved ejection fraction","volume":"167","author":"Eapen","year":"2014","journal-title":"Am Heart J"},{"key":"key\n\t\t\t\t2018122103591472700_ehy626-B7","first-page":"44","article-title":"Predictors and prognostic implications of incident heart failure in patients with prevalent atrial fibrillation","volume":"5","author":"Pandey","year":"2017","journal-title":"JACC Heart Fail"},{"key":"key\n\t\t\t\t2018122103591472700_ehy626-B8","first-page":"1111","article-title":"Clinical and prognostic effects of atrial fibrillation in heart failure patients with reduced and preserved left ventricular ejection fraction","volume":"13","author":"Linssen","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"key\n\t\t\t\t2018122103591472700_ehy626-B9","first-page":"1997","article-title":"Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program","volume":"47","author":"Olsson","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t2018122103591472700_ehy626-B10","first-page":"565","article-title":"Atrial fibrillation in heart failure with preserved, mid-range, and reduced ejection fraction","volume":"5","author":"Sartipy","year":"2017","journal-title":"JACC Heart Fail"},{"key":"key\n\t\t\t\t2018122103591472700_ehy626-B11","first-page":"e005694","article-title":". Atrial fibrillation and outcomes in heart failure with preserved versus reduced left ventricular ejection fraction","volume":"2","author":"McManus","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"key\n\t\t\t\t2018122103591472700_ehy626-B12","first-page":"484","article-title":"Atrial fibrillation begets heart failure and vice versa: temporal associations and differences in preserved versus reduced ejection fraction","volume":"133","author":"Santhanakrishnan","year":"2016","journal-title":"Circulation"},{"key":"key\n\t\t\t\t2018122103591472700_ehy626-B13","first-page":"295","article-title":"Ejection fraction and outcomes in patients with atrial fibrillation and heart failure: the Loire Valley Atrial Fibrillation Project","volume":"14","author":"Banerjee","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"key\n\t\t\t\t2018122103591472700_ehy626-B14","first-page":"1317","article-title":"The prognostic significance of atrial fibrillation in heart failure with a preserved and reduced left ventricular function: insights from a meta-analysis","volume":"16","author":"Cheng","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"key\n\t\t\t\t2018122103591472700_ehy626-B15","first-page":"660","article-title":"Atrial fibrillation and heart failure due to reduced versus preserved ejection fraction: a systematic review and meta-analysis of death and adverse outcomes","volume":"203","author":"Kotecha","year":"2016","journal-title":"Int J Cardiol"},{"key":"key\n\t\t\t\t2018122103591472700_ehy626-B16","first-page":"676","article-title":"A meta-analysis of the prognostic significance of atrial fibrillation in chronic heart failure","volume":"11","author":"Mamas","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"key\n\t\t\t\t2018122103591472700_ehy626-B17","first-page":"1173","article-title":"Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12,440 patients of the ESC Heart Failure Long-Term Registry","volume":"15","author":"Maggioni","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"key\n\t\t\t\t2018122103591472700_ehy626-B18","first-page":"613","article-title":"European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-year follow-up outcomes and differences across regions","volume":"18","author":"Crespo-Leiro","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"key\n\t\t\t\t2018122103591472700_ehy626-B19","first-page":"2516","article-title":"Atrial fibrillation and heart failure: treatment considerations for a dual epidemic","volume":"119","author":"Anter","year":"2009","journal-title":"Circulation"},{"key":"key\n\t\t\t\t2018122103591472700_ehy626-B20","first-page":"265","article-title":"Mid-range left ventricular ejection fraction: clinical profile and cause of death in ambulatory patients with chronic heart failure","volume":"240","author":"Pascual-Figal","year":"2017","journal-title":"Int J Cardiol"},{"key":"key\n\t\t\t\t2018122103591472700_ehy626-B21","first-page":"124","article-title":"Heart failure with mid-range ejection fraction in patients admitted to internal medicine departments: findings from the RICA Registry","volume":"255","author":"Guisado-Espartero","year":"2018","journal-title":"Int J Cardiol"},{"key":"key\n\t\t\t\t2018122103591472700_ehy626-B22","first-page":"2217","article-title":"Heart failure with preserved ejection fraction and atrial fibrillation: vicious twins","volume":"68","author":"Kotecha","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t2018122103591472700_ehy626-B23","first-page":"417","article-title":"Catheter ablation for atrial fibrillation with heart failure","volume":"378","author":"Marrouche","year":"2018","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2018122103591472700_ehy626-B24","first-page":"468","article-title":"Paradigm shift for treatment of atrial fibrillation in heart failure","volume":"378","author":"Link","year":"2018","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2018122103591472700_ehy626-B25","first-page":"651","article-title":"Catheter ablation of atrial fibrillation in patients with heart failure and preserved ejection fraction","volume":"15","author":"Black-Maier","year":"2018","journal-title":"Heart Rhythm"},{"key":"key\n\t\t\t\t2018122103591472700_ehy626-B26","first-page":"26","article-title":"Beta-blockers for heart failure with reduced, mid-range and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials","volume":"39","author":"Cleland","year":"2018","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t2018122103591472700_ehy626-B27","first-page":"1230","article-title":"Heart failure with mid-range ejection fraction in CHARM: characteristics, outcomes and effect of candesartan across the entire ejection fraction spectrum","volume":"20","author":"Lund","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"key\n\t\t\t\t2018122103591472700_ehy626-B28","first-page":"942","article-title":"Left ventricular heart failure and pulmonary hypertension. Left ventricular heart failure and pulmonary hypertension","volume":"37","author":"Rosenkranz","year":"2016","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t2018122103591472700_ehy626-B29","first-page":"2893","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/eurheartj\/article-pdf\/39\/48\/4277\/27206071\/ehy626.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T03:47:16Z","timestamp":1589946436000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/39\/48\/4277\/5133012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,15]]},"references-count":29,"journal-issue":{"issue":"48","published-online":{"date-parts":[[2018,10,15]]},"published-print":{"date-parts":[[2018,12,21]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehy626","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,12,21]]},"published":{"date-parts":[[2018,10,15]]}}}